IMU 0.00% 10.5¢ imugene limited

Media Thread, page-106

  1. 602 Posts.
    lightbulb Created with Sketch. 324
    I think there would have to be more than one. For starters, GSK is one that most probably needs someone else to bid first. Then there is Mercks who knows PH well and he knows them well. Then Gilead would have to be watching as they have gone hard in this area and wouldn't like to have a competitor outsmart them. When they purchased IMMU for $21 B they mentioned that they had access to more funds for other purchases. Another $21 B no problem!
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
10.5¢
Change
0.000(0.00%)
Mkt cap ! $768.4M
Open High Low Value Volume
10.5¢ 10.8¢ 10.0¢ $746.7K 7.120M

Buyers (Bids)

No. Vol. Price($)
161 9473412 10.0¢
 

Sellers (Offers)

Price($) Vol. No.
10.5¢ 259241 4
View Market Depth
Last trade - 16.10pm 29/03/2024 (20 minute delay) ?
Last
10.3¢
  Change
0.000 ( 2.40 %)
Open High Low Volume
10.3¢ 10.5¢ 10.3¢ 1930285
Last updated 15.59pm 29/03/2024 ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.